Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$22.41
At close: Jun 24 EDT
$22.41
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
ACADIA Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:ACAD | Benzinga
ACADIA Pharmaceuticals Inc has a consensus price target of $28.5 based on the ratings of 25 analysts. The high is $42 issued by Cantor Fitzgerald on August 22, 2023. The low is $19 issued by Oppenheimer on May 6, 2024. The 3 most-recent analyst ratings were released by RBC Capital, JP Morgan, and B of A Securities on June 23, 2025, June 6, 2025, and June 5, 2025, respectively. With an average price target of $30.33 between RBC Capital, JP Morgan, and B of A Securities, there's an implied 35.36% upside for ACADIA Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
JP Morgan
B of A Securities
Deutsche Bank
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for ACADIA Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/23/2025 | Buy Now | 69.57% | RBC Capital | Brian Abrahams49% | $26 → $38 | Maintains | Outperform | Get Alert |
| 06/06/2025 | Buy Now | 33.87% | JP Morgan | Tessa Romero60% | $26 → $30 | Maintains | Overweight | Get Alert |
| 06/05/2025 | Buy Now | 2.63% | B of A Securities | Tazeen Ahmad56% | $18 → $23 | Maintains | Neutral | Get Alert |
| 05/21/2025 | Buy Now | 56.18% | Deutsche Bank | David Hoang41% | $20 → $35 | Upgrade | Hold → Buy | Get Alert |
| 05/20/2025 | Buy Now | 7.1% | Morgan Stanley | Jeffrey Hung51% | $20 → $24 | Maintains | Equal-Weight | Get Alert |
| 05/19/2025 | Buy Now | 2.63% | Mizuho | Uy Ear59% | $20 → $23 | Maintains | Neutral | Get Alert |
| 05/19/2025 | Buy Now | 38.33% | Baird | Joel Beatty68% | $28 → $31 | Maintains | Outperform | Get Alert |
| 05/19/2025 | Buy Now | 16.02% | RBC Capital | Gregory Renza49% | $26 → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 05/19/2025 | Buy Now | 24.94% | BMO Capital | Evan David Seigerman48% | $24 → $28 | Maintains | Outperform | Get Alert |
| 05/19/2025 | Buy Now | 42.79% | HC Wainwright & Co. | Andrew Fein61% | $27 → $32 | Maintains | Buy | Get Alert |
| 05/19/2025 | Buy Now | 33.87% | Needham | Ami Fadia60% | $27 → $30 | Maintains | Buy | Get Alert |
| 04/28/2025 | Buy Now | -1.83% | UBS | Ashwani Verma47% | $25 → $22 | Maintains | Buy | Get Alert |
| 04/08/2025 | Buy Now | 24.94% | Needham | Ami Fadia60% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/07/2025 | Buy Now | -10.75% | Morgan Stanley | Jeffrey Hung51% | $20 → $20 | Assumes | → Equal-Weight | Get Alert |
| 02/27/2025 | Buy Now | 24.94% | Cantor Fitzgerald | Charles Duncan69% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 02/27/2025 | Buy Now | 20.48% | HC Wainwright & Co. | Andrew Fein61% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2025 | Buy Now | 24.94% | Needham | Ami Fadia60% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 02/11/2025 | Buy Now | -1.83% | Deutsche Bank | Neena Bitritto-Garg58% | → $22 | Initiates | → Hold | Get Alert |
| 01/03/2025 | Buy Now | -10.75% | Guggenheim | Yatin Suneja55% | $20 → $20 | Downgrade | Buy → Neutral | Get Alert |
| 11/07/2024 | Buy Now | 24.94% | Needham | Ami Fadia60% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2024 | Buy Now | 20.48% | HC Wainwright & Co. | Andrew Fein61% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 10/10/2024 | Buy Now | — | Raymond James | Danielle Brill42% | — | Reinstates | → Market Perform | Get Alert |
| 08/08/2024 | Buy Now | 2.63% | Citigroup | David Hoang41% | $30 → $23 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 2.63% | UBS | Ashwani Verma47% | $25 → $23 | Maintains | Buy | Get Alert |
| 08/08/2024 | Buy Now | 20.48% | HC Wainwright & Co. | Andrew Fein61% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | 24.94% | Needham | Ami Fadia60% | $30 → $28 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 24.94% | Cantor Fitzgerald | Charles Duncan69% | $37 → $28 | Maintains | Overweight | Get Alert |
| 08/07/2024 | Buy Now | 16.02% | RBC Capital | Gregory Renza49% | $29 → $26 | Maintains | Outperform | Get Alert |
| 08/07/2024 | Buy Now | -10.75% | Morgan Stanley | Jeffrey Hung51% | $28 → $20 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/12/2024 | Buy Now | 24.94% | Morgan Stanley | Jeffrey Hung51% | $30 → $28 | Maintains | Overweight | Get Alert |
| 06/27/2024 | Buy Now | 38.33% | BMO Capital | Keith Tapper52% | → $31 | Initiates | → Outperform | Get Alert |
| 06/25/2024 | Buy Now | 29.41% | RBC Capital | Gregory Renza49% | $29 → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2024 | Buy Now | -1.83% | B of A Securities | Tazeen Ahmad56% | $26 → $22 | Maintains | Neutral | Get Alert |
| 05/09/2024 | Buy Now | 33.87% | Needham | Ami Fadia60% | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 65.1% | Cantor Fitzgerald | Charles Duncan69% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | Buy Now | 20.48% | HC Wainwright & Co. | Andrew Fein61% | $33 → $27 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 33.87% | Citigroup | David Hoang41% | $30.19 → $30 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | -6.29% | Stifel | Paul Matteis44% | $26 → $21 | Maintains | Hold | Get Alert |
| 05/09/2024 | Buy Now | -6.29% | Mizuho | Uy Ear59% | $25 → $21 | Maintains | Neutral | Get Alert |
| 05/09/2024 | Buy Now | 24.94% | Baird | Joel Beatty68% | $31 → $28 | Maintains | Outperform | Get Alert |
| 05/06/2024 | Buy Now | -15.22% | Oppenheimer | Jay Olson60% | $19 → $19 | Maintains | Perform | Get Alert |
| 04/30/2024 | Buy Now | 20.48% | UBS | Ashwani Verma47% | $33 → $27 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 65.1% | Cantor Fitzgerald | Charles Duncan69% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | 65.1% | Cantor Fitzgerald | Charles Duncan69% | $37 → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 04/09/2024 | Buy Now | 42.79% | Needham | Ami Fadia60% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2024 | Buy Now | 11.56% | JP Morgan | Tessa Romero60% | $29 → $25 | Maintains | Overweight | Get Alert |
| 03/13/2024 | Buy Now | 33.87% | Morgan Stanley | Jeffrey Hung51% | $40 → $30 | Maintains | Overweight | Get Alert |
| 03/12/2024 | Buy Now | 34.72% | Citigroup | David Hoang41% | $38 → $30.19 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 33.87% | RBC Capital | Gregory Renza49% | $35 → $30 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | 11.56% | Mizuho | Uy Ear59% | $39 → $25 | Downgrade | Buy → Neutral | Get Alert |
| 03/12/2024 | Buy Now | 74.03% | JMP Securities | Jason Butler51% | $44 → $39 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | 65.1% | Cantor Fitzgerald | Charles Duncan69% | $42 → $37 | Maintains | Overweight | Get Alert |
| 03/12/2024 | Buy Now | 38.33% | Baird | Joel Beatty68% | $40 → $31 | Maintains | Outperform | Get Alert |
| 03/12/2024 | Buy Now | -15.22% | Oppenheimer | Jay Olson60% | $25 → $19 | Maintains | Perform | Get Alert |
| 03/12/2024 | Buy Now | 33.87% | B of A Securities | Tazeen Ahmad56% | $33 → $30 | Maintains | Neutral | Get Alert |
| 03/12/2024 | Buy Now | 47.26% | Canaccord Genuity | Sumant Kulkarni43% | $40 → $33 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 47.26% | HC Wainwright & Co. | Andrew Fein61% | → $33 | Reiterates | Buy → Buy | Get Alert |
| 03/12/2024 | Buy Now | 42.79% | Needham | Ami Fadia60% | $36 → $32 | Maintains | Buy | Get Alert |
| 03/01/2024 | Buy Now | 29.41% | JP Morgan | Tessa Romero60% | $32 → $29 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | 47.26% | HC Wainwright & Co. | Andrew Fein61% | $33 → $33 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | 87.42% | Cantor Fitzgerald | Charles Duncan69% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 02/28/2024 | Buy Now | 56.18% | RBC Capital | Gregory Renza49% | $36 → $35 | Maintains | Outperform | Get Alert |
| 02/28/2024 | Buy Now | 74.03% | Mizuho | Uy Ear59% | $40 → $39 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 60.64% | Needham | Ami Fadia60% | $37 → $36 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | 87.42% | JMP Securities | Jason Butler51% | $42 → $42 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/05/2024 | Buy Now | 11.56% | Oppenheimer | Jay Olson60% | → $25 | Reiterates | Perform → Perform | Get Alert |
| 02/02/2024 | Buy Now | 87.42% | Cantor Fitzgerald | Charles Duncan69% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 01/30/2024 | Buy Now | 78.49% | Baird | Joel Beatty68% | → $40 | Initiates | → Outperform | Get Alert |
| 01/24/2024 | Buy Now | 65.1% | Needham | Joseph Stringer61% | → $37 | Upgrade | Hold → Buy | Get Alert |
| 12/29/2023 | Buy Now | 78.49% | Mizuho | Uy Ear59% | $35 → $40 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | 78.49% | Morgan Stanley | Jeffrey Hung51% | $31 → $40 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/18/2023 | Buy Now | 20.48% | Stifel | Paul Matteis44% | $25 → $27 | Maintains | Hold | Get Alert |
| 12/14/2023 | Buy Now | 87.42% | Cantor Fitzgerald | Charles Duncan69% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 12/14/2023 | Buy Now | 11.56% | Deutsche Bank | Neena Bitritto-Garg58% | → $25 | Downgrade | Buy → Hold | Get Alert |
| 12/13/2023 | Buy Now | 69.57% | Citigroup | David Hoang41% | → $38 | Initiates | → Buy | Get Alert |
| 12/12/2023 | Buy Now | 11.56% | Deutsche Bank | Neena Bitritto-Garg58% | → $25 | Initiates | → Buy | Get Alert |
| 11/06/2023 | Buy Now | 78.49% | Canaccord Genuity | Sumant Kulkarni43% | $38 → $40 | Maintains | Buy | Get Alert |
| 11/06/2023 | Buy Now | 56.18% | Mizuho | Uy Ear59% | $20 → $35 | Upgrade | Neutral → Buy | Get Alert |
| 11/03/2023 | Buy Now | 87.42% | JMP Securities | Jason Butler51% | $39 → $42 | Maintains | Market Outperform | Get Alert |
| 11/03/2023 | Buy Now | 47.26% | RBC Capital | Gregory Renza49% | $32 → $33 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | 38.33% | Morgan Stanley | Jeffrey Hung51% | $30 → $31 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 47.26% | UBS | Ashwani Verma47% | → $33 | Initiates | → Buy | Get Alert |
| 10/10/2023 | Buy Now | 42.79% | JP Morgan | Tessa Romero60% | $29 → $32 | Upgrade | Neutral → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 87.42% | Cantor Fitzgerald | Sarah James51% | → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 08/07/2023 | Buy Now | 29.41% | JP Morgan | Tessa Romero60% | $28 → $29 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | 69.57% | Canaccord Genuity | Sumant Kulkarni43% | $39 → $38 | Maintains | Buy | Get Alert |
| 08/03/2023 | Buy Now | 33.87% | Morgan Stanley | Jeffrey Hung51% | $30 → $30 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | 11.56% | Oppenheimer | Jay Olson60% | → $25 | Reiterates | Perform → Perform | Get Alert |
| 08/03/2023 | Buy Now | 47.26% | HC Wainwright & Co. | Andrew Fein61% | → $33 | Reiterates | Buy → Buy | Get Alert |
| 07/28/2023 | Buy Now | 11.56% | Oppenheimer | Jay Olson60% | $23 → $25 | Maintains | Perform | Get Alert |
| 07/17/2023 | Buy Now | 74.03% | Canaccord Genuity | Sumant Kulkarni43% | $28 → $39 | Maintains | Buy | Get Alert |
| 07/17/2023 | Buy Now | 87.42% | Cantor Fitzgerald | Sarah James51% | $36 → $42 | Maintains | Overweight | Get Alert |
| 07/14/2023 | Buy Now | 47.26% | RBC Capital | Gregory Renza49% | $28 → $33 | Maintains | Outperform | Get Alert |
| 07/14/2023 | Buy Now | 20.48% | Citigroup | Neena Bitritto-Garg58% | $21.6 → $27 | Maintains | Neutral | Get Alert |
| 07/14/2023 | Buy Now | 33.87% | Morgan Stanley | Jeffrey Hung51% | $21 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/14/2023 | Buy Now | 74.03% | JMP Securities | Jason Butler51% | $31 → $39 | Maintains | Market Outperform | Get Alert |
| 07/14/2023 | Buy Now | 2.63% | Oppenheimer | Jay Olson60% | $20 → $23 | Maintains | Perform | Get Alert |
| 07/14/2023 | Buy Now | 47.26% | HC Wainwright & Co. | Andrew Fein61% | $28 → $33 | Maintains | Buy | Get Alert |
| 07/11/2023 | Buy Now | -6.29% | Morgan Stanley | Jeffrey Hung51% | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 06/14/2023 | Buy Now | 38.33% | JMP Securities | Jason Butler51% | $23 → $31 | Maintains | Market Outperform | Get Alert |
FAQ
What is the target price for ACADIA Pharmaceuticals (ACAD) stock?
The latest price target for ACADIA Pharmaceuticals (NASDAQ:ACAD) was reported by RBC Capital on June 23, 2025. The analyst firm set a price target for $38.00 expecting ACAD to rise to within 12 months (a possible 69.57% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ACADIA Pharmaceuticals (ACAD)?
The latest analyst rating for ACADIA Pharmaceuticals (NASDAQ:ACAD) was provided by RBC Capital, and ACADIA Pharmaceuticals maintained their outperform rating.
When was the last upgrade for ACADIA Pharmaceuticals (ACAD)?
The last upgrade for ACADIA Pharmaceuticals Inc happened on May 21, 2025 when Deutsche Bank raised their price target to $35. Deutsche Bank previously had a hold for ACADIA Pharmaceuticals Inc.
When was the last downgrade for ACADIA Pharmaceuticals (ACAD)?
The last downgrade for ACADIA Pharmaceuticals Inc happened on January 3, 2025 when Guggenheim changed their price target from $20 to $20 for ACADIA Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for ACADIA Pharmaceuticals (ACAD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ACADIA Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ACADIA Pharmaceuticals was filed on June 23, 2025 so you should expect the next rating to be made available sometime around June 23, 2026.
Is the Analyst Rating ACADIA Pharmaceuticals (ACAD) correct?
While ratings are subjective and will change, the latest ACADIA Pharmaceuticals (ACAD) rating was a maintained with a price target of $26.00 to $38.00. The current price ACADIA Pharmaceuticals (ACAD) is trading at is $22.41, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
